Pacira Biosciences moved up less than 1% today. The market isn't being very decisive in its valuation of Drug Manufacturers company.
Currently PCRX isn't at a clear support/resistance line that seems tradable. Pacira Biosciences hasn't shown a lot of strength recently, shareholders don't seem that energized about the Drug Manufacturers company's future prospects. PCRX might find some support at the 35.49 level, buyers might push the price back up from here. But it's not very clear what will happen.
The analysts feel fairly neutral on the prospects for Pacira BioSciences but a little more positive than negative. The current Analysts Sentiment Score is 10.46. Most companies range between (-200 to 200).
Here's a break down of the latest rating changes. Royal Bank of Canada announced a lowering of their price target to $45.00 from $53.00 on 2024-03-01. Needham & Company LLC announced that they are reiterating a rating of Buy on 2024-03-01 and they set their price target at $45.00. On 2024-02-08 there was confirmation of the previous rating by Wedbush which was Outperform and provided a price target of $57.00. Raymond James initiated a rating of Outperform on 2023-12-20 and added a price target of $42.00. HC Wainwright announced a lowering of their price target to $57.00 from $63.00 on 2023-11-06. Piper Sandler announced a lowering of their price target to $42.00 from $50.00 on 2023-11-03. On 2023-10-23 Barclays lowered their price target by -5% to $57.00. Truist Financial decided to move down their price target on 2023-08-03 to $55.00 which is a -8.33% decrease. TD Cowen upgraded from Market Perform to Outperform on 2023-08-03 and added a price target of $50.00.
Company | Ratings Score
?
Composite analyst sentiment score
|
Positive Ratings | Negative Ratings | Boost Price Target | Lower Price Target |
---|---|---|---|---|---|
PCRX | 10.46 | 12.17 | 0 | 11.27 | -2.53 |
Company | YOY Growth Score (typical -20 to +20) | Revision Directions (-6 to +6) |
---|---|---|
PCRX | 0.00 | 0.00 |
We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.
Company | Short Score (typical 1-15)
?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
|
Short Interest | Days to Cover | Rate of Change | Shares Short |
---|---|---|---|---|---|
PCRX | 9.03 | %8.82353 | 7.7 | 15.642 | 3930000 |
Segment | Count | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest | Analysts Ratings ? |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Drug Manufacturers | 19 | -0.36 | -0.71 | -6.61 | -9.88 | -2.49 | 4.91 | 37.21 | 1.55 | 0.91 | 4.71 | -9443.66 | -7551.57 | 0.00 | 22.37 | 4.88 | 5.23 |
Healthcare | 230 | 0.11 | 0.41 | 0.04 | -2.76 | 5.84 | 26.79 | 53.66 | 8.86 | 8.57 | 8.32 | -12704.99 | -11984.82 | 18.91 | 4.24 | 6.74 | 5.54 |
Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.
Ticker | Social Sentiment(1-10) |
---|---|
PCRX |
Company | Score | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest Score |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SAGE | Sage Therapeutics, Inc | 0.65 | 2.04 | -1.76 | -37.45 | -38.07 | -57.47 | -74.22 | 31 | -168.21 | -178.82 | -69.30 | -149709.64 | -1968.67 | 0 | 0 | 12.6533 |
KURA | Kura Oncology, Inc. | 0.61 | -36.90 | -36.93 | -42.66 | -51.05 | -52.57 | 6.92 | 59 | -12.34 | -8.94 | -6.18 | -4497.47 | -12834.13 | 0 | 0 | 7.89025 |
KALV | KalVista Pharmaceuticals, | 0.58 | -2.23 | -7.69 | -25.00 | -32.62 | -22.48 | 15.57 | 36 | -14.27 | -7.37 | -8.61 | -7346.84 | -5302.54 | 0 | 0 | 16.0787 |
DGII | Digi International Inc | 0.55 | 0.54 | 0.99 | 6.23 | 9.12 | 27.54 | 29.00 | 72 | 45.17 | 23.89 | 27.06 | -2278.57 | -15235.33 | 0 | 0 | 8.5097 |
How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.